Jazz Pharma director uses 1,706 shares for tax

Jazz Pharmaceuticals plc (JAZZ) director Norbert G. Riedel reported dispositions of Ordinary Shares on August 31, 2026 to cover tax obligations from the vesting of previously granted restricted stock units.

Rhea-AI Filing Summary

Jazz Pharmaceuticals plc (JAZZ) director Norbert G. Riedel reported dispositions of Ordinary Shares on August 31, 2026 to cover tax obligations from the vesting of previously granted restricted stock units. A total of 1,706 shares were delivered or withheld for taxes, and an entity-related trust holds 10,630 Ordinary Shares indirectly after the reported transactions. No Rule 10b5-1 trading plan is reported.

Insider Trade Summary

Tax Withholding: 1,706 shares

Tax Withholding 3 txns

Insider RIEDEL NORBERT G

Role Director

Type	Security	Shares	Price	Value
Tax Withholding	Ordinary Shares F1	14	$244.6443	$3K
Tax Withholding	Ordinary Shares F1	1,692	$241.39	$408K
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Ordinary Shares — 6,923 shares (Direct); Ordinary Shares — 10,630 shares (Indirect, by Trust)

Footnotes (1)

1. F1. Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

Key Figures

Shares used for tax obligations: 1,706 shares Tax shares block 1: 14 shares at $244.6443 per share Tax shares block 2: 1,692 shares at $241.39 per share +2 more

5 metrics

Shares used for tax obligations 1,706 shares Total Ordinary Shares delivered or withheld for tax obligations on August 31, 2026

Tax shares block 1 14 shares at $244.6443 per share Ordinary Shares used for tax obligations on August 31, 2026

Tax shares block 2 1,692 shares at $241.39 per share Ordinary Shares used for tax obligations on August 31, 2026

Indirect holdings by Trust 10,630 shares Ordinary Shares held indirectly by Trust after reported transactions

Exercise-price-or-tax-liability transactions 2 transactions, 1,706 shares total Code F transactions reported in the Form 4

Key Terms

restricted stock units, tax obligations, Ordinary Shares

3 terms

restricted stock units financial

"vesting of previously granted restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax obligations financial

"Shares sold to satisfy tax obligations arising out of the vesting"

Ordinary Shares financial

"Ordinary Shares used to satisfy tax obligations"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider activity did JAZZ director Norbert G. Riedel report on August 31, 2026?

He reported using 1,706 Ordinary Shares on August 31, 2026 to satisfy tax obligations arising from the vesting of previously granted restricted stock units, via share delivery or withholding rather than an open-market sale.

How many Jazz Pharmaceuticals (JAZZ) shares were involved in each Form 4 tax transaction?

Two transactions were reported: 14 Ordinary Shares at $244.6443 per share and 1,692 Ordinary Shares at $241.39 per share, both used to pay tax obligations related to vesting restricted stock units.

Does the August 31, 2026 Form 4 for JAZZ indicate use of a Rule 10b5-1 trading plan?

No. The filing’s Rule 10b5-1 checkbox is not affirmed, and there is no footnote stating that the transactions were made under a Rule 10b5-1 or other pre-arranged trading plan.

What is the nature of the remaining Jazz Pharmaceuticals (JAZZ) holdings reported by the insider?

The Form 4 shows an indirect holding of 10,630 Ordinary Shares held by Trust. This reflects shares held through a trust rather than directly in the insider’s own name.

Were the JAZZ Form 4 transactions open-market sales by the director?

No. Both transactions are coded F and described as payment of tax liability by delivering or withholding securities, with a footnote stating shares were sold to satisfy tax obligations from RSU vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/02/2026 - 05:31 PM EDT Accepted by SEC EDGAR 09/02/2026 - 05:31 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

RIEDEL NORBERT G

(Last) (First) (Middle)

5TH FL, WATERLOO EXCHANGE

WATERLOO RD

(Street)

DUBLIN 4

(City) (State) (Zip)

IRELAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
Jazz Pharmaceuticals plc [ JAZZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/31/2026		F(1)		14	D	$244.6443	8,615	D
Ordinary Shares	08/31/2026		F(1)		1,692	D	$241.39	6,923	D
Ordinary Shares								10,630	I	by Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

	By: /s/Paz Dizon, as attorney in fact For: Norbert G Riedel	09/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)